Cancer research
Allopurinol Exerts Cytotoxicity on Human Prostate Cancer Cells in Combination with TRAIL
Researchers from Kyoto, Japan, have discovered that allopurinol, a commonly used medication for treating gout, possesses anticancer properties when combined with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). The study, published in Molecular Cancer Research, found that allopurinol induced apoptosis in human hormone-refractory prostate cancer cells in combination with TRAIL, which